Track Medline Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Medline Inc. MDLN · Stock Open Medline Inc. in new tab

39.47 USD
P/E
90.09
EPS
0.44
P/B
2.95
ROE
4.85
Target Price
45.31 USD
Medline Inc. logo

Medline Inc.

🧾 Earnings Recap – Q3 2026

Medline’s shares rose 18.4% after earnings, with investors responding to 10% sales growth and 12% growth in adjusted EBITDA. The quarter also showed margin pressures from inflation, customer mix, and higher operating expenses, while management flagged near-term pressure and ongoing quality investments.

  • Third-quarter net sales increased 10% year over year to $7.9 billion, driven almost entirely by organic growth.
  • Adjusted EBITDA rose 12% to $1 billion; management cited strong sales and tariff refunds as tailwinds, partly offset by higher operating expenses, inflation-related costs, and customer mix.
  • Supply Chain Solutions sales grew 14% to $4.2 billion, while Medline Brand sales increased 7% to $3.6 billion.
  • U.S. acute care sales grew 12% to $5.5 billion; nonacute care rose 6% to $1.9 billion. International sales increased 8% to $518 million.
  • Management said near-term margin pressure remains a focus. Global quality assessments across more than 30 manufacturing sites are expected to take multiple years; related investments are reflected in 2026 guidance and the 2027 framework.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 24, 2027
P/E90.09
EPS0.44
Book Value13.43
Price to Book2.95
Debt/Equity65.24
% Insiders0.257%
Growth
Revenue Growth0.10%
Earnings Growth10.88%
Estimates
Forward P/E25.46
Forward EPS1.56
Target Mean Price45.31

DCF valuation

Model fair value for Medline Inc. (MDLN)
Result
Sign in to run the valuation for MDLN.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
26 analysts · consensus Buy · mean target 45.31 USD (low 34.00, high 55.00) · as of 9 Nov 2026
Low 34.00
Mean 45.31
High 55.00
Price 39.47
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Medline Inc. Logo Medline Inc. Analysis (MDLN)

Is Medline Inc. a good investment? Medline Inc. (MDLN) is currently trading at 39.47 USD. Market analysts have a consensus price target of 45.31 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 90.09. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Medline Inc. is expected to release its next earnings report on Feb. 24, 2027. The market consensus estimate for Forward EPS is 1.56.

Investor FAQ

Does Medline Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Medline Inc.?

Medline Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of 0.44.

Company Profile

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Exchange Ticker
MDLN
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion